Poststroke Depression in Hemorrhagic Stroke

Study overview

A double-blinded placebo-controlled randomized trial to evaluate the effect of preventative treatment of depression in survivors of aneurysmal subarachnoid hemorrhage (aSAH), a type of stroke.

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

University of Washington,

Michael Levitt, MD, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

2024-11-30